Alnylam Pharmaceuticals reported $2.47B in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Amgen AMGN:US $ 19322M 802M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Avrobio Inc AVRO:US 142.08M 28.84M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
IONIS PHARMACEUT IONS:US $ 2191.15M 61.98M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Moderna Inc MRNA:US 13.56B 2.79B
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Novartis NVS:US $ 38142M 906M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Regulus Therapeutics RGLS:US $ 51.4M 6.54M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Takeda 4502:JP Y 2549515M 44127M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
Xencor XNCR:US $ 585.94M 79.97M
YTE INCY:US $ 3625.84M 337.75M